• Something wrong with this record ?

Microbiota alteration at different stages in gastric lesion progression: a population-based study in Linqu, China

G. Kadeerhan, M. Gerhard, JJ. Gao, R. Mejías-Luque, L. Zhang, M. Vieth, JL. Ma, M. Bajbouj, S. Suchanek, WD. Liu, K. Ulm, M. Quante, ZX. Li, T. Zhou, R. Schmid, M. Classen, WQ. Li, Y. Zhang, WC. You, KF. Pan

. 2021 ; 11 (2) : 561-575. [pub] 20210201

Language English Country United States

Document type Journal Article

In addition to Helicobacter pylori (H.pylori), gastric microbiota may be involved in carcinogenesis process. However, the longitudinal study to assess changes in the gastric microbiota associated with the development of gastric carcinogenesis is still limited. The aim of this study is to explore dynamic microbial alterations in gastric cancer (GC) development based on a 4-year endoscopic follow-up cohort in Linqu County, China. Microbial alterations were investigated by deep sequencing of the microbial 16S ribosomal RNA gene in 179 subjects with various gastric lesions, and validated in paired gastric biopsies prospectively collected before and after lesion progression and in non-progression controls. Significant differences were found in microbial diversity and community structure across various gastric lesions, with 62 candidate differential taxa between at least two lesion groups. Further validations identified Helicobacter, Bacillus, Capnocytophaga and Prevotella to be associated with lesion progression-to-dysplasia (DYS)/GC (all P < 0.05), especially for subjects progressing from intestinal metaplasia (IM) to DYS/GC. The combination of the four genera in a microbial dysbiosis index showed a significant difference after lesion progression-to-DYS/GC compared to controls (P = 0.027). The panel including the four genera identified subjects after progression-to-DYS/GC with an area under the receiver-operating curve (AUC) of 0.941. Predictive significance was found before lesion progression-to-DYS/GC with an AUC = 0.776 and an even better AUC (0.927) for subjects progressing from IM to DYS/GC. Microbiota may play different roles at different stages in gastric carcinogenesis. A panel of bacterial genera associated with gastric lesions may help to assess gastric microbial dysbiosis and show potential predictive values for lesion progression. Our findings provide new clues for the microbial mechanism of H.pylori-associated carcinogenesis.

000      
00000naa a2200000 a 4500
001      
bmc21010552
003      
CZ-PrNML
005      
20210715153718.0
007      
ta
008      
210413s2021 xxu f 000 0|eng||
009      
AR
035    __
$a (PubMed)33575087
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kadeerhan, Gaohaer $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China
245    10
$a Microbiota alteration at different stages in gastric lesion progression: a population-based study in Linqu, China / $c G. Kadeerhan, M. Gerhard, JJ. Gao, R. Mejías-Luque, L. Zhang, M. Vieth, JL. Ma, M. Bajbouj, S. Suchanek, WD. Liu, K. Ulm, M. Quante, ZX. Li, T. Zhou, R. Schmid, M. Classen, WQ. Li, Y. Zhang, WC. You, KF. Pan
520    9_
$a In addition to Helicobacter pylori (H.pylori), gastric microbiota may be involved in carcinogenesis process. However, the longitudinal study to assess changes in the gastric microbiota associated with the development of gastric carcinogenesis is still limited. The aim of this study is to explore dynamic microbial alterations in gastric cancer (GC) development based on a 4-year endoscopic follow-up cohort in Linqu County, China. Microbial alterations were investigated by deep sequencing of the microbial 16S ribosomal RNA gene in 179 subjects with various gastric lesions, and validated in paired gastric biopsies prospectively collected before and after lesion progression and in non-progression controls. Significant differences were found in microbial diversity and community structure across various gastric lesions, with 62 candidate differential taxa between at least two lesion groups. Further validations identified Helicobacter, Bacillus, Capnocytophaga and Prevotella to be associated with lesion progression-to-dysplasia (DYS)/GC (all P < 0.05), especially for subjects progressing from intestinal metaplasia (IM) to DYS/GC. The combination of the four genera in a microbial dysbiosis index showed a significant difference after lesion progression-to-DYS/GC compared to controls (P = 0.027). The panel including the four genera identified subjects after progression-to-DYS/GC with an area under the receiver-operating curve (AUC) of 0.941. Predictive significance was found before lesion progression-to-DYS/GC with an AUC = 0.776 and an even better AUC (0.927) for subjects progressing from IM to DYS/GC. Microbiota may play different roles at different stages in gastric carcinogenesis. A panel of bacterial genera associated with gastric lesions may help to assess gastric microbial dysbiosis and show potential predictive values for lesion progression. Our findings provide new clues for the microbial mechanism of H.pylori-associated carcinogenesis.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gerhard, Markus $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China ; Institute of Medical Microbiology, Immunology and Hygiene, Technische Universität München Munich, Germany ; German Center for Infection Research, Partner Site Munich Munich, Germany
700    1_
$a Gao, Juan-Juan $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China
700    1_
$a Mejías-Luque, Raquel $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China ; Institute of Medical Microbiology, Immunology and Hygiene, Technische Universität München Munich, Germany ; German Center for Infection Research, Partner Site Munich Munich, Germany
700    1_
$a Zhang, Lian $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China
700    1_
$a Vieth, Michael $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China ; Institute of Pathology, Klinikum Bayreuth Bayreuth, Germany
700    1_
$a Ma, Jun-Ling $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China
700    1_
$a Bajbouj, Monther $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China ; II. Medizinische Klinik, Klinikum Rechts der Isar, Technische Universität München Munich, Germany
700    1_
$a Suchanek, Stepan $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China ; Department of Medicine, 1st Faculty of Medicine, Military University Hospital, Charles University Prague, Czech Republic
700    1_
$a Liu, Wei-Dong $u Linqu Public Health Bureau Linqu, Shandong, China
700    1_
$a Ulm, Kurt $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China ; Institute of Medical Informatics, Statistics and Epidemiology, Technische Universität München Munich, Germany
700    1_
$a Quante, Michael $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China ; II. Medizinische Klinik, Klinikum Rechts der Isar, Technische Universität München Munich, Germany
700    1_
$a Li, Zhe-Xuan $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China ; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China
700    1_
$a Zhou, Tong $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China
700    1_
$a Schmid, Roland $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China ; II. Medizinische Klinik, Klinikum Rechts der Isar, Technische Universität München Munich, Germany
700    1_
$a Classen, Meinhard $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China ; International Digestive Cancer Alliance Germany
700    1_
$a Li, Wen-Qing $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China
700    1_
$a Zhang, Yang $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China ; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China
700    1_
$a You, Wei-Cheng $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China ; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China
700    1_
$a Pan, Kai-Feng $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China ; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China
773    0_
$w MED00188728 $t American journal of cancer research $x 2156-6976 $g Roč. 11, č. 2 (2021), s. 561-575
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33575087 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20210413 $b ABA008
991    __
$a 20210715153717 $b ABA008
999    __
$a ind $b bmc $g 1649852 $s 1130928
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 11 $c 2 $d 561-575 $e 20210201 $i 2156-6976 $m American journal of cancer research $n Am J Cancer Res $x MED00188728
LZP    __
$a Pubmed-20210413

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...